Financials
- Market Capitalization 215.46 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.54
Relación precio/flujo de caja
29.09
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3548 | KROS Keros Therapeutics, Inc. - common stock | 11.12 USD | +0.36% | -2.20% | +9.45% | -26.36% | 220.48 M USD | ||
| 3563 | GLSI Greenwich LifeSciences, Inc. - Common stock | 14.69 USD | -1.74% | -22.85% | +8.81% | +26.64% | 215.62 M USD | ||
| 3566 | PEPG PepGen Inc. - Common Stock | 3.09 USD | +3.34% | -7.49% | +74.58% | +164.10% | 214.01 M USD | ||
| 3570 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.94 USD | +3.16% | -6.96% | +35.48% | +117.78% | 212.61 M USD |